6:09 PM
 | 
Nov 12, 2012
 |  BC Extra  |  Company News

Foundation Medicine, AstraZeneca in cancer deal

Foundation Medicine Inc. (Cambridge, Mass.) and AstraZeneca plc (LSE:AZN; NYSE:AZN) partnered...

Read the full 42 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >